hypertension
- Managing hypertension in cardiology practice according to risk profile.
- Evidence-Based Medicine: Cardiovascular Strategies to Improve Outcome.
- Exploring the Potential of Angiotensin II Antagonists in Cardiovascular Management.
- Transferring Evidence-Based Cardioprotection into Clinical Practice.
- Hypertension Treatment: First Do No Harm.
- Setting New Standards for the AII Antagonist Class.
- Innovations in the Management of the Hypertensive Patient in 2008.
- Sexual Dysfunction in Patients with Hypertension. Deleterious Effects on Quality of Life and Ability to Stay on Therapy.
- Prevention and Treatment of Stroke in Patients with Hypertension.
- AII antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan.
- Role of Angiotensin II in Cardiovascular Disease – Therapeutic Implications of More Than a Century of Research.
- Review of the molecular pharmacology of losartan and its possible relevance to stroke prevention in patients with hypertension.
- Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
- Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
- Do Angiotensin II Antagonists Provide Benefits Beyond Blood Pressure Reduction?
- Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
